Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-25

Clinical Trial Update: Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment

View source ↗

Summary

The ARMOR study registry describes ablation of renal masses and its impact on quality of life, sponsored by Memorial Sloan Kettering Cancer Center. The trial is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Renal Cancer | Status: ACTIVE_NOT_RECRUITING